Core Viewpoint - The article discusses the controversy surrounding the use of Tylenol (acetaminophen) during pregnancy and its alleged link to autism, particularly in light of statements made by former President Trump, which have been widely refuted by health organizations and experts [3][4][5]. Group 1: Statements from Health Organizations - The World Health Organization (WHO) stated that there is currently no conclusive scientific evidence linking the use of acetaminophen during pregnancy to autism [4][6]. - The European Medicines Agency also indicated that existing evidence does not support a connection between the use of acetaminophen during pregnancy and autism, recommending the lowest effective dose if needed [7]. - The UK Medicines and Healthcare products Regulatory Agency (MHRA) warned that following Trump's advice could harm unborn babies, emphasizing that there is no evidence linking acetaminophen use during pregnancy to autism [7][8]. Group 2: Research Findings - A significant study led by epidemiologist Viktor Ahlqvist analyzed data from nearly 2.5 million children born in Sweden from 1995 to 2019, finding a very small difference in autism rates between children exposed to acetaminophen (1.42%) and those not exposed (1.33%) [9][10]. - The study also compared siblings, which showed no association between acetaminophen use and autism, suggesting that previous findings may be explained by confounding factors rather than the drug itself [10]. - A separate high-quality study from Japan involving over 200,000 children also concluded that there is no link between acetaminophen use during pregnancy and autism [10].
WHO最新回应来了!特朗普称孕妇吃泰诺会引发儿童自闭症
第一财经·2025-09-24 12:10